Log in
Enquire now
Elegen

Elegen

Elegen is a company is developing a patent-pending microfluidics technology for usage in synthetic biology. The technology is focused on engineering of genomes and development of immunotherapies for cancer.

OverviewStructured DataIssuesContributors

Contents

elegenbio.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Genetics
Genetics
Synthetic biology
Synthetic biology
Biology
Biology
Genomics
Genomics
Biomedical engineering
Biomedical engineering
Biotechnology
Biotechnology
Engineering
Engineering
...
Location
San Francisco
San Francisco
United States
United States
San Carlos, California
San Carlos, California
B2X
B2B
B2B
CEO
‌
Matt Hill
0
‌
Matthew Hill
Founder
‌
Matt Hill
0
‌
Matthew Hill
Number of Employees (Ranges)
11 – 500
Email Address
Full Address
1300 Industrial Road #16, San Carlos, CA 94070
Founded Date
2017
0
Patents Assigned (Count)
1
Country
United States
United States

Other attributes

Company Operating Status
Active

Elegen is a company is developing a patent-pending microfluidics technology for usage in synthetic biology. The technology is focused on engineering of genomes and development of immunotherapies for cancer.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Elegen

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.